Report Detail

Pharma & Healthcare Global mRNA Platform Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • RnM4359062
  • |
  • 20 December, 2021
  • |
  • Global
  • |
  • 85 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

The mRNA Platform market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global mRNA Platform size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global mRNA Platform market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
mRNA Platform market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Infectious Disease Vaccines
Cancer Vaccines

Market segment by Application, can be divided into
Infectious Disease
Cancer

Market segment by players, this report covers
Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe mRNA Platform product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of mRNA Platform, with revenue, gross margin and global market share of mRNA Platform from 2019 to 2021.
Chapter 3, the mRNA Platform competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and mRNA Platform market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe mRNA Platform research findings and conclusion, appendix and data source.


1 Market Overview

  • 1.1 Product Overview and Scope of mRNA Platform
  • 1.2 Classification of mRNA Platform by Type
    • 1.2.1 Overview: Global mRNA Platform Market Size by Type: 2020 Versus 2021 Versus 2026
    • 1.2.2 Global mRNA Platform Revenue Market Share by Type in 2020
    • 1.2.3 Infectious Disease Vaccines
    • 1.2.4 Cancer Vaccines
  • 1.3 Global mRNA Platform Market by Application
    • 1.3.1 Overview: Global mRNA Platform Market Size by Application: 2020 Versus 2021 Versus 2026
    • 1.3.2 Infectious Disease
    • 1.3.3 Cancer
  • 1.4 Global mRNA Platform Market Size & Forecast
  • 1.5 Global mRNA Platform Market Size and Forecast by Region
    • 1.5.1 Global mRNA Platform Market Size by Region: 2016 VS 2021 VS 2026
    • 1.5.2 Global mRNA Platform Market Size by Region, (2016-2021)
    • 1.5.3 North America mRNA Platform Market Size and Prospect (2016-2026)
    • 1.5.4 Europe mRNA Platform Market Size and Prospect (2016-2026)
    • 1.5.5 Asia-Pacific mRNA Platform Market Size and Prospect (2016-2026)
    • 1.5.6 South America mRNA Platform Market Size and Prospect (2016-2026)
    • 1.5.7 Middle East and Africa mRNA Platform Market Size and Prospect (2016-2026)
  • 1.6 Market Drivers, Restraints and Trends
    • 1.6.1 mRNA Platform Market Drivers
    • 1.6.2 mRNA Platform Market Restraints
    • 1.6.3 mRNA Platform Trends Analysis

2 Company Profiles

  • 2.1 Arcturus Therapeutic
    • 2.1.1 Arcturus Therapeutic Details
    • 2.1.2 Arcturus Therapeutic Major Business
    • 2.1.3 Arcturus Therapeutic mRNA Platform Product and Solutions
    • 2.1.4 Arcturus Therapeutic mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
    • 2.1.5 Arcturus Therapeutic Recent Developments and Future Plans
  • 2.2 Argos Therapeutics
    • 2.2.1 Argos Therapeutics Details
    • 2.2.2 Argos Therapeutics Major Business
    • 2.2.3 Argos Therapeutics mRNA Platform Product and Solutions
    • 2.2.4 Argos Therapeutics mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
    • 2.2.5 Argos Therapeutics Recent Developments and Future Plans
  • 2.3 BioNTec
    • 2.3.1 BioNTec Details
    • 2.3.2 BioNTec Major Business
    • 2.3.3 BioNTec mRNA Platform Product and Solutions
    • 2.3.4 BioNTec mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
    • 2.3.5 BioNTec Recent Developments and Future Plans
  • 2.4 CureVac
    • 2.4.1 CureVac Details
    • 2.4.2 CureVac Major Business
    • 2.4.3 CureVac mRNA Platform Product and Solutions
    • 2.4.4 CureVac mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
    • 2.4.5 CureVac Recent Developments and Future Plans
  • 2.5 Etherna
    • 2.5.1 Etherna Details
    • 2.5.2 Etherna Major Business
    • 2.5.3 Etherna mRNA Platform Product and Solutions
    • 2.5.4 Etherna mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
    • 2.5.5 Etherna Recent Developments and Future Plans
  • 2.6 Ethris
    • 2.6.1 Ethris Details
    • 2.6.2 Ethris Major Business
    • 2.6.3 Ethris mRNA Platform Product and Solutions
    • 2.6.4 Ethris mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
    • 2.6.5 Ethris Recent Developments and Future Plans
  • 2.7 GlaxoSmithKline
    • 2.7.1 GlaxoSmithKline Details
    • 2.7.2 GlaxoSmithKline Major Business
    • 2.7.3 GlaxoSmithKline mRNA Platform Product and Solutions
    • 2.7.4 GlaxoSmithKline mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
    • 2.7.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.8 Pfizer
    • 2.8.1 Pfizer Details
    • 2.8.2 Pfizer Major Business
    • 2.8.3 Pfizer mRNA Platform Product and Solutions
    • 2.8.4 Pfizer mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
    • 2.8.5 Pfizer Recent Developments and Future Plans
  • 2.9 Translate Bio
    • 2.9.1 Translate Bio Details
    • 2.9.2 Translate Bio Major Business
    • 2.9.3 Translate Bio mRNA Platform Product and Solutions
    • 2.9.4 Translate Bio mRNA Platform Revenue, Gross Margin and Market Share (2019-2021)
    • 2.9.5 Translate Bio Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global mRNA Platform Revenue and Share by Players (2019-2021)
  • 3.2 Market Concentration Rate
    • 3.2.1 Top 3 mRNA Platform Players Market Share
    • 3.2.2 Top 10 mRNA Platform Players Market Share
    • 3.2.3 Market Competition Trend
  • 3.3 mRNA Platform Players Head Office, Products and Services Provided
  • 3.4 Mergers & Acquisitions
  • 3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

  • 4.1 Global mRNA Platform Revenue and Market Share by Type (2016-2021)
  • 4.2 Global mRNA Platform Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

  • 5.1 Global mRNA Platform Revenue Market Share by Application (2016-2021)
  • 5.2 mRNA Platform Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

  • 6.1 North America mRNA Platform Revenue by Type (2016-2026)
  • 6.2 North America mRNA Platform Revenue by Application (2016-2026)
  • 6.3 North America mRNA Platform Market Size by Country
    • 6.3.1 North America mRNA Platform Revenue by Country (2016-2026)
    • 6.3.2 United States mRNA Platform Market Size and Forecast (2016-2026)
    • 6.3.3 Canada mRNA Platform Market Size and Forecast (2016-2026)
    • 6.3.4 Mexico mRNA Platform Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

  • 7.1 Europe mRNA Platform Revenue by Type (2016-2026)
  • 7.2 Europe mRNA Platform Revenue by Application (2016-2026)
  • 7.3 Europe mRNA Platform Market Size by Country
    • 7.3.1 Europe mRNA Platform Revenue by Country (2016-2026)
    • 7.3.2 Germany mRNA Platform Market Size and Forecast (2016-2026)
    • 7.3.3 France mRNA Platform Market Size and Forecast (2016-2026)
    • 7.3.4 United Kingdom mRNA Platform Market Size and Forecast (2016-2026)
    • 7.3.5 Russia mRNA Platform Market Size and Forecast (2016-2026)
    • 7.3.6 Italy mRNA Platform Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

  • 8.1 Asia-Pacific mRNA Platform Revenue by Type (2016-2026)
  • 8.2 Asia-Pacific mRNA Platform Revenue by Application (2016-2026)
  • 8.3 Asia-Pacific mRNA Platform Market Size by Region
    • 8.3.1 Asia-Pacific mRNA Platform Revenue by Region (2016-2026)
    • 8.3.2 China mRNA Platform Market Size and Forecast (2016-2026)
    • 8.3.3 Japan mRNA Platform Market Size and Forecast (2016-2026)
    • 8.3.4 South Korea mRNA Platform Market Size and Forecast (2016-2026)
    • 8.3.5 India mRNA Platform Market Size and Forecast (2016-2026)
    • 8.3.6 Southeast Asia mRNA Platform Market Size and Forecast (2016-2026)
    • 8.3.7 Australia mRNA Platform Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

  • 9.1 South America mRNA Platform Revenue by Type (2016-2026)
  • 9.2 South America mRNA Platform Revenue by Application (2016-2026)
  • 9.3 South America mRNA Platform Market Size by Country
    • 9.3.1 South America mRNA Platform Revenue by Country (2016-2026)
    • 9.3.2 Brazil mRNA Platform Market Size and Forecast (2016-2026)
    • 9.3.3 Argentina mRNA Platform Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

  • 10.1 Middle East & Africa mRNA Platform Revenue by Type (2016-2026)
  • 10.2 Middle East & Africa mRNA Platform Revenue by Application (2016-2026)
  • 10.3 Middle East & Africa mRNA Platform Market Size by Country
    • 10.3.1 Middle East & Africa mRNA Platform Revenue by Country (2016-2026)
    • 10.3.2 Turkey mRNA Platform Market Size and Forecast (2016-2026)
    • 10.3.3 Saudi Arabia mRNA Platform Market Size and Forecast (2016-2026)
    • 10.3.4 UAE mRNA Platform Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

    12 Appendix

    • 12.1 Methodology
    • 12.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on mRNA Platform. Industry analysis & Market Report on mRNA Platform is a syndicated market report, published as Global mRNA Platform Market 2021 by Company, Regions, Type and Application, Forecast to 2026. It is complete Research Study and Industry Analysis of mRNA Platform market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,803.50
    5,607.00
    3,269.00
    6,538.00
    551,215.00
    1,102,430.00
    291,865.00
    583,730.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report